VISCHER advises Oberland Capital on its agreement with Helsinn

As we have informed here, the Helsinn Group has closed a financing agreement with Oberland Capital Management. In this sense, VISCHER has advised Oberland Capital Management on its financing agreement with the Ticino based group.

Oberland Capital is a private investment firm with assets under management in excess of USD 3 bn, focused exclusively on investing in the global healthcare industry and specializing in flexible investment structures customized to meet the specific needs of its transaction partners. The Helsinn Group is a fully integrated, global biopharma group with a track record of over 40 years of commercial execution and a strong focus in oncology and rare diseases.

VISCHER has acted as Swiss legal advisor to Oberland Capital in this transaction. The team was led by partner Adrian Dörig (banking & finance, pictured) and included partner Christoph Niederer (tax), Jana Essebier (partner, banking & finance), Jonas Gassmann (counsel, IP), Seraina Jenny-Tsering (managing associate, banking & finance), Christian Schneiter (senior associate, banking & finance), Patrik Fisch (senior associate, tax), Livia Camenisch (associate, IP) and Dorothea Wirth (junior associate, banking & finance).